Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Rockyciano1on Jul 10, 2019 8:30am

80 Views

Post# 29902901

RE:Revenue delayed

Nevertheless, these are great news and many will follow.

I am with you. Things will take a while. So it is time to load.

But the things will come. And this is for sure.

So do not cry when Sirona is doing things step by step and you forgot to come in.

My opinion and my way to handle with Sirona. Time haven't been better for Sirona than nowadays and the next months.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?